BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4773968)

  • 21. [Gout from the view of a special hospital for rheumatic patients].
    Klotz H; Prohaska E; Salmhofer H; Schmid L
    Wien Klin Wochenschr; 1971 Mar; 83(11):177-80. PubMed ID: 5314855
    [No Abstract]   [Full Text] [Related]  

  • 22. Pyrazolidines in the treatment of gout.
    Kuzell WC
    Can Med Assoc J; 1968 Nov; 99(21):1038-43. PubMed ID: 5721943
    [No Abstract]   [Full Text] [Related]  

  • 23. [Current etiopathogenetic and therapeutic views concerning gout and hyperuremic syndromes].
    Ravera M
    Minerva Med; 1973 Jan; 64(4):144-56. PubMed ID: 4686682
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of gout.
    Simkin PA
    Ann Intern Med; 1979 May; 90(5):812-6. PubMed ID: 434690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gout and uric acid metabolism.
    Arthritis Rheum; 1970; 13(5):553-69. PubMed ID: 4922854
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pathogenesis and therapy of gout].
    Mertz DP
    Med Klin; 1971 Apr; 66(17):623-6. PubMed ID: 4994876
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug therapy reviews: pathogenesis and clinical management of hyperuricemia and gout.
    Mangini RJ
    Am J Hosp Pharm; 1979 Apr; 36(4):497-504. PubMed ID: 433935
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapy of gout].
    Fontana M
    Clin Ter; 1978 Feb; 84(4):441-7. PubMed ID: 648101
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapeutic agents for gout effecting the kidney].
    Ueda Y; Kono H; Kobayashi Y; Kagawa K; Yonezawa H
    Geka Chiryo; 1970 Mar; 22(3):317-22. PubMed ID: 5467650
    [No Abstract]   [Full Text] [Related]  

  • 30. Uricosuric activity of suxibuzone, a new phenylbutazone derivative.
    Erill S; Laporte J
    Arch Farmacol Toxicol; 1975 Mar; 1(1):43-6. PubMed ID: 1231648
    [No Abstract]   [Full Text] [Related]  

  • 31. Drugs for gout.
    Med Lett Drugs Ther; 1976 Jun; 18(12):49-51. PubMed ID: 934016
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of gout.
    Gordon GV; Schumacher HR
    Am Fam Physician; 1979 Jan; 19(1):91-7. PubMed ID: 760433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The management of gout.
    McCarty DJ
    Hosp Pract; 1979 Sep; 14(9):75-8, 83-5. PubMed ID: 478531
    [No Abstract]   [Full Text] [Related]  

  • 34. Pathogenesis and clinical management of hyperuricemia and gout.
    Mangini RJ
    J Maine Med Assoc; 1979 Mar; 70(3):118-20, 122-7. PubMed ID: 374661
    [No Abstract]   [Full Text] [Related]  

  • 35. Drugs in the treatment of hyperuricemia.
    Elion GB
    Adv Nephrol Necker Hosp; 1974; 3():51-7. PubMed ID: 4219708
    [No Abstract]   [Full Text] [Related]  

  • 36. The treatment of gout.
    Barnes CG
    Practitioner; 1972 Jan; 208(243):101-6. PubMed ID: 5015124
    [No Abstract]   [Full Text] [Related]  

  • 37. Gout and other crystalline forms of arthritis.
    Rodnan GP
    Postgrad Med; 1975 Oct; 58(5):6-14. PubMed ID: 170600
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hyperuricemia and gout--treatment].
    Gröbner W; Walter-Sack I
    Dtsch Med Wochenschr; 2002 Feb; 127(5):210-3. PubMed ID: 11821994
    [No Abstract]   [Full Text] [Related]  

  • 39. Medical management of gout.
    Gutman AB
    Postgrad Med; 1972 May; 51(6):61-6. PubMed ID: 5028822
    [No Abstract]   [Full Text] [Related]  

  • 40. Therapeutics of hyperuricaemia and gout.
    Emmerson BT
    Med J Aust; 1984 Jul; 141(1):31-6. PubMed ID: 6738408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.